Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH/ISH 2016 | Hematology-Oncology programs within the UK’s hematology community

Mark Caulfield • 18 Apr 2016
BSH/ISH 2016
General

Mark Caulfield, MD from the Genomics England and Queen Mary University, London, UK discusses aspects on the UK hematology community. The UK hematology community with some international partners is shaping a hematology-oncology programs focusing on blood cancers which have unmet needs in regards to diagnostic and stratified healthcare. Programs are primarily built around clinical trials and aim to test the effectiveness of medication and how to select the correct medicine for patients.
Recorded at the 2016 Annual Meeting of the British Society of Haematology (BSH) and International Society of Hematology (ISH) in Glasgow, Scotland.

More from Mark Caulfield

Understanding the drivers behind disease with the 100,000 Genomes Project
4:32
Understanding the drivers behind disease with the 100,000 Genomes Project
Mark Caulfield • 18 Apr 2016

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals